SpyGlass Pharma, Inc. (SGP)
Nasdaq: SGP · Surgical & Medical Instruments & Apparatus · Aliso Viejo, CA · filing with the SEC since 2019
Who owns SpyGlass Pharma, Inc.
As filed with the SECHolders of 5% or more
6
RA Capital Management, L.P. holds 24.1% of Common Stock, $0.00001 par value per share, as its SCHEDULE 13D filed Feb 17, 2026 says.
Directors and officers
18
report now, of 18 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
RA Capital Management, L.P.
SCHEDULE 13D · filed Feb 17, 2026 · Common Stock, $0.00001 par value per share
New Enterprise Associates 17, L.P.
SCHEDULE 13D · filed Feb 13, 2026 · Common Stock, $0.00001 par value per share
Vensana Capital I GP, LLC
SCHEDULE 13D · filed Feb 10, 2026 · Common Stock, par value $0.00001 per share
Sands Frank M.
SCHEDULE 13G · filed Feb 13, 2026 · Common Stock, $0.00001 par value per share
Gilde Healthcare Holding B.V.
SCHEDULE 13D · filed Feb 13, 2026 · Common Stock, par value $0.00001 per share
Srinivas Akkaraju
SCHEDULE 13G · filed Feb 17, 2026 · Common Stock, $0.00001 par value per share
What SGP reports owning in othersstakes of 5% or more, and other ties
SpyGlass Pharma, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
7purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$83.8Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window15 of 32 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Khan Bilal Arshad | director | 0 | $0 | 0 | 2 | $2.2M |
| Ra Capital Healthcare Fund LP | director | 0 | $0 | 0 | 2 | $59.0M |
| Behbahani Ali | director | 0 | $0 | 0 | 1 | $15.0M |
| Nielsen Kirk G. | director | 0 | $0 | 0 | 1 | $2.6M |
| Pardo Geoffrey B | director | 0 | $0 | 0 | 1 | $5.0M |
| Baskett Forest | 10% owner | 0 | $0 | 0 | 1 | $15.0M |
| Chang Carmen | 10% owner | 0 | $0 | 0 | 1 | $15.0M |
| Florence Anthony A. Jr. | 10% owner | 0 | $0 | 0 | 1 | $15.0M |
| Makhzoumi Mohamad | 10% owner | 0 | $0 | 0 | 1 | $15.0M |
| Mathers Edward T | 10% owner | 0 | $0 | 0 | 1 | $15.0M |
| Nea 17 Gp, LLC | 10% owner | 0 | $0 | 0 | 1 | $15.0M |
| Sandell Scott D | 10% owner | 0 | $0 | 0 | 1 | $15.0M |
| Walker Paul Edward | 10% owner | 0 | $0 | 0 | 1 | $15.0M |
| Yang Rick | 10% owner | 0 | $0 | 0 | 1 | $15.0M |
| Vensana Capital I Gp, LLC | 10% owner | 0 | $0 | 0 | 1 | $2.6M |